TKNO stock icon

Alpha Teknova

6.54 USD
-0.08
1.21%
Updated Oct 22, 10:44 AM EDT
1 day
-1.21%
5 days
5.31%
1 month
33.47%
3 months
188.11%
6 months
227.00%
Year to date
72.11%
1 year
209.95%
5 years
-73.84%
 

About: Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.

Employees: 211

0
Funds holding %
of 6,740 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

0.56% less ownership

Funds ownership: 14.91% [Q1] → 14.35% (-0.56%) [Q2]

10% less funds holding

Funds holding: 31 [Q1] → 28 (-3) [Q2]

25% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 12

49% less capital invested

Capital invested by funds: $15.8M [Q1] → $8.03M (-$7.79M) [Q2]

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Research analyst outlook

We haven’t received any recent analyst ratings for TKNO.

Financial journalist opinion

Charts implemented using Lightweight Charts™